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Sepsis-induced diaphragmatic inﬂammation has been associated with respiratory failure, but the role of chemokines in this
process has not been evaluated. Here we sought to study the local expression and molecular regulation of the chemokines,
regulated upon activation normal T cell expressed and secreted (RANTES) and macrophage inﬂammatory protein (MIP)-1α,i n
the murine diaphragm during sepsis. Constitutive expression levels of RANTES and MIP-1α, as well as their receptors, CCR1 and
CCR5, were signiﬁcantly higher in diaphragm than limb muscle. Sepsis was induced by acute lipopolysaccharide (LPS) delivery
or subacutely by intratracheal administration of live Pseudomonas aeruginosa bacteria. Both sepsis models triggered a marked
upregulation of RANTES and MIP-1α in the diaphragm. In vitro, stimulation of diaphragmatic muscle cells with LPS also led to
RANTES upregulation. Inhibition of the NF-kB pathway using pharmacologic or dominant negative genetic approaches blocked
the LPS-induced RANTES upregulation, while free radical scavengers had no eﬀect. We conclude that sepsis leads to greatly
increased expression of RANTES, MIP-1α and their cognate receptors in the diaphragm. Manipulation of the NF-kB pathway
and other regulators of chemokine expression in the diaphragm could represent a novel method for mitigating the skeletal muscle
inﬂammatory response associated with sepsis-induced diaphragmatic dysfunction.
Copyright © 2009 Alexandre Demoule et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Diaphragmatic dysfunction likely plays an important role in
sepsis-relatedrespiratoryfailure,acondition whichoccursin
a large proportion of patients admitted to the ICU for severe
sepsis [1]. Sepsis-induced diaphragmatic dysfunction is a
pleiomorphic phenomenon manifested by decreased force-
generating capacity of the muscle, an increased susceptibility
to fatigue, and the presence of muscle ﬁber injury [2–7].
Inﬂammatory mechanisms have been strongly implicated,
witho xygenfreeradicals[8–10],nitricoxideoritsderivatives
[4, 5], and TNF-α [11, 12] being amongst the major
mediators identiﬁed thus far.
The potential involvement of chemokines in this process
has not been examined to date. Chemokines are low-
molecular-weight cytokines that play a key role in orches-
trating leukocyte traﬃcking to infected or diseased tissues.
The chemokines are subdivided into four main families
(CC, CXC, CX3C, and C) based upon their structure [13].
Increased expression levels of several chemokine ligands and
their cognate receptors, particularly of the CC family, have
been found in muscle biopsies obtained from animal models
and human patients suﬀering from muscular dystrophy or
inﬂammatory myopathies [14–16]. In this regard, we have
recently reported a marked upregulation of CCR1 and two
of its major ligands, RANTES (CCL5) and MIP-1α (CCL3),
in the diaphragms of muscular dystrophy (mdx) mice and
demonstrated a relationship with the degree of muscle
inﬁltration by mononuclear inﬂammatory cells [16].
In addition to their classical role as leukocyte chemoat-
tractants, the chemokines inﬂuence a diverse repertoire of
normal and pathophysiologic processes, including myoblast
behavior in skeletal muscle repair [17–19]a n dt i s s u e
responses to oxidative stress [20]. RANTES and MIP-1α can2 Mediators of Inﬂammation
also act together with IFN-γ to synergistically upregulate
TNF-α [21], the most prototypical cytokine implicated in
sepsis-induced diaphragmatic dysfunction. Furthermore, it
has recently been demonstrated that the CCR1-RANTES
axis is a key modulator of the host immune response to
bacterial peritonitis [22] as well as exogenously administered
LPS [23].
In the present study, our primary objective was to
determine whether RANTES and MIP-1α,a sw e l la st h e i r
major receptors, are upregulated within the diaphragm after
the induction of sepsis in vivo. To examine this question, we
employed two diﬀerent models of sepsis in vivo, an acute
model of systemic LPS administration and a more “clinically
realistic” model of sustained sepsis caused by Pseudomonas
lung infection. We further dissected the cellular mechanisms
underlyingchemokineupregulationinthesepticdiaphragm,
by examining the responses of primary diaphragm muscle
cells to LPS stimulation in vitro. More speciﬁcally, we sought
to ascertain whether these responses could be inﬂuenced by
inhibiting either free radicals or the NF-κB transcription
factor pathway, since both have been implicated in sepsis-
associated respiratory muscle dysfunction.
2.MaterialsandMethods
2.1. Animal Models of Sepsis. All animal procedures were
approved by the institutional animal care committee. Male
C57BL/6 mice (Charles River, Quebec, Canada) aged 8–
10 weeks (23–26g) were studied. Anesthesia was achieved
with a mixture of ketamine (Fort Dodge Animal Health,
Fort Dodge, IA) and xylazine (Bayer, Shawnee Mission,
KS). Two experimental models of infection were used: acute
endotoxemia and Pseudomonas aeruginosa lung infection.
Toproduceendotoxemia,animalsreceivedanintraperitoneal
injection of LPS (25mg/kg of serotype O55:B5; Sigma
Chemical Co., St Louis, MO) diluted in saline. In previous
studies, such a dose has been shown to produce a signiﬁcant
impairmentofdiaphragmaticforcegeneration[24].Asham-
treated control group underwent the same procedure with
an equivalent volume of saline alone, and all mice were
euthanized at either 6 or 24 hours after injection.
The model of chronic pulmonary infection with P.
aeruginosa was performed as originally reported by Starke
et al. [25], with minor modiﬁcations as we have previously
described in detail [7] .T h eb a c t e r i aw e r ee n t r a p p e dw i t h i n
agar beads (100–150μm), and the number of viable bacteria
was measured by homogenizing the beads and then plating
10-fold serial dilutions on trypticase soy agar plates. Sterile
agar beads were produced in the same manner but with
omissionofbacteriaandwereconﬁrmedtobefreeofcolony-
forming units (CFUs). The trachea of anesthetized mice was
intubated to deliver either bacteria-containing or sterile agar
beads to mouse lungs, and the mice were killed at either 2
or 7 days later. Two diﬀerent doses of inoculating bacteria
(2 × 105 and 1 × 106cfu) were studied at 2 days after
infection, whereas only the lower inoculating dose was used
for the 7-day time point due to unacceptable signs of ill
health at the higher dose in the 7-day group. The higher
dose has been shown to produce a signiﬁcant impairment of
diaphragm force generation 2 days after infection, whereas
the lower dose has been shown to produce similar eﬀects 7
days after infection [7].
2.2. Primary Muscle Cell Cultures. Primary diaphragm and
tibialis anterior (TA) muscle cell cultures were established
as previously described in detail [16], using single living
muscle ﬁbers to isolate adult myoblasts. Brieﬂy, excised
diaphragm muscle strips were digested (0.2% collagenase),
followed by trituration to liberate individual ﬁbers. The
ﬁbers were transferred into Matrigel (Becton Dickinson,
Franklin Lakes, NJ)-coated (1mg/mL in DMEM) 6-well
plates. Cultures were maintained in DMEM with 10% horse
serum and 0.5% chick embryo extract (MP Biomedical,
Aurora, OH) for 4 days, during which myoblasts attached
to the substratum. Diaphragmatic myoblasts were then
expanded in growth medium (20% fetal bovine serum,
10% horse serum, 1% chick embryo extract in DMEM)
until attaining approximately 75% conﬂuence. At this point,
the cultures were placed in diﬀerentiation medium (2%
fetal bovine serum, 10% horse serum, 0.5% chick embryo
extract in DMEM) in order to induce myoblast fusion into
diﬀerentiated myotubes. All experiments were performed on
the ﬁfth day in diﬀerentiation medium.
For LPS stimulation, the cells were washed with DMEM
and then stimulated during 4 hours with E. Coli LPS
(1μg/mL). To study the involvement of NF-κB, myotubes
were treated one hour before LPS exposure with pyrroli-
dine dithiocarbamate (PDTC; at 100μM) (Fisher Scientiﬁc,
Nepean, ON), a compound which inhibits the ubiquitin
E3 ligase function required for NF-κBa c t i v a t i o n[ 26, 27].
To study the potential role of free radicals, myotubes were
treated with catalase (at 2000U/mL) or N-acetylcysteine
(NAC; at 10mM) (Fisher Scientiﬁc, Nepean, ON), initiated
one hour before LPS exposure [28].
2.3. Muscle Cell Transfections. Because the transfection eﬃ-
ciency of primary muscle cell cultures is very low [29],
a murine myoblast cell line (C2C12) was employed for
transfection experiments. C2C12 cells (5 ×105) were seeded
onto 60mm plates, incubated overnight in growth medium
(DMEM-10% FBS), and transfected the following day at
approximately 60% conﬂuence. To achieve transfection,
Lipofectamine 2000TM (Invitrogen, Carlbad, CA) and 8μg
of plasmid DNA were combined according to the manu-
facturer’s protocol. At 48 hours posttransfection, the cells
were trypsinized, replated in 6-well plates and allowed to
attach overnight. The next day the medium was switched to
DMEM-2% HS to induce diﬀerentiation, and LPS stimula-
tionexperimentswereperformedondiﬀerentiatedmyotubes
5 days later, as described earlier for primary cells. Cells
transfected with pEGFP-C1 (BD Bioscience, Clontech, San
Diego, CA), expressing green ﬂuorescent protein (GFP),
served as transfection controls.
To evaluate transcriptional activity from the RANTES
promoter, muscle cells were transfected with a ﬁreﬂy
luciferase expression plasmid under the control of theMediators of Inﬂammation 3
RANTES promoter (gift from Moriuchi et al. [30]). The cells
were exposed to LPS for 4 hours, then lysed and assayed
for luciferase activity. To assess the involvement of NF-κB
in chemokine gene regulation, dominant negative mutant
forms of the IκB kinases (gift from Bhakar et al. [31]), IKKα,
and IKKβ were employed to inhibit NF-κB activation.
2.4. Ribonuclease Protection Assays. The mRNA expression
levels of CCR1 and CCR5 as well as their two major ligands,
RANTES and MIP-1α, were assessed in RNA extracted from
tissuesormusclecellculturesusing Trizol(Invitrogen,Carls-
bad, CA). The labelled riboprobes were hybridized with total
RNA overnight (20 micrograms from muscle tissues and 5
micrograms from muscle cell cultures) and then processed
using the manufacturer’s protocol (BD Bioscience, Pharmin-
gen, San Diego, CA). Protected mRNAs were separated using
a 5% acrylamide gel (19:1 acrylamide:bisacrylamide). Gels
were transferred to ﬁlter paper and dried under vacuum
using a gel drier. Dried gels were exposed to scientiﬁc X-
ray imaging ﬁlm (Kodak, Rochester, NY), and the bands
were quantiﬁed using an image analysis system (FluorChem
8000, Alpha Innotech Corp, San Leandro, CA). All signals
were normalized to L32 as a loading control and expressed in
absolute arbitrary units.
2.5. Statistical Analyses. V a l u e sa r ee x p r e s s e da sm e a n s±
SE. For both in vivo and in vitro studies, 6 independent
replicate analyses were performed for each experimental
condition and time point, unless otherwise noted. For
the same experimental condition, diaphragm and TA were
compared using the Wilcoxon sign rank test. For the same
type of muscle, LPS and saline groups were compared using
the Mann-Whitney Rank Sum test. Comparisons between
three or more groups were performed using the Kruskall-
Wallis test. When signiﬁcant, post hoc multiple comparisons
were archived using the Student-Newman-Keuls method.
The analysis was performed using SigmaStat software
(SPSS, Chicago, IL), and statistical signiﬁcance was set at
P<. 05.
3. Results
3.1. Endotoxemia Upregulates Expression of CCR1 and Its
Ligands,RANTESandMIP-1α,withintheDiaphragmInVivo.
To ascertain the eﬀects of endotoxemia on CCR1 and CCR5
expression in the diaphragm and TA muscles, total RNA
was extracted at 6 or 24 hours after LPS administration and
analyzed by ribonuclease protection assays. A representative
autoradiograph showing CCR1 expression levels at 24 hours
after LPS delivery, as well as group mean data (expressed
in arbitrary units) for both time points, are provided in
Figure 1. It should be noted that for these experiments, all of
the RNA samples evaluated for a speciﬁc time point (n = 24)
were loaded onto the same gel in order to ensure that the
X-ray exposure conditions were identical. This allowed for
valid quantitative comparisons at a given time point but not
necessarily between diﬀerent time points, and thus only the
former was subjected to statistical analysis. As can be seen,
CCR1andCCR5werebothexpressedatahigherconstitutive
level in the diaphragm than in the TA limb muscle under
control (saline) conditions. However, only CCR1 showed
upregulation in the diaphragm during sepsis, and this was
observedatthe24-hourtimepoint.Interestingly,bothCCR1
and CCR5 were signiﬁcantly upregulated in the TA muscle at
6 hours after LPS administration.
We next sought to evaluate whether the observed upreg-
ulation of CCRs in the septic diaphragm and TA is associated
with altered expression of their cognate ligands, RANTES
and MIP-1α, at the same time points (6 and 24 hours)
after LPS delivery in vivo. Figure 2 shows that the overall
patterns of RANTES and MIP-1α gene expression responses
were similar. Hence for both chemokines, increased mRNA
expression was induced by LPS injection in the diaphragm
at 6 hours, and levels remained elevated over control values
at 24 hours. In addition, under control conditions, the
baseline expression levels of both RANTES and MIP-1α
were signiﬁcantly higher in the diaphragm than in the TA
limb muscle. Similarly, the absolute magnitude of mRNA
expression for both chemokines after LPS administration
was generally greater in the diaphragm than in the limb
muscle.
3.2. RANTES and MIP-1α are Upregulated in the Diaphragm
during Sustained Pseudomonas Lung Infection. To determine
if similar patterns of chemokine upregulation within the
diaphragm are observed in another septic situation rele-
vant to the ICU setting, namely, gram-negative bacterial
pneumonia, a live infection with Pseudomonas aeruginosa
was introduced into the lungs. Two diﬀerent inoculating
doses were studied at Day 2 postinfection, whereas only
the lower inoculating dose was used for Day 7 due to
excessive mortality at this time point with the higher dose.
Figure 3 shows that both RANTES and MIP-1α mRNA
expression were upregulated at Day 2 postinfection with
the higher inoculating dose (106 cfu) only. In contrast, the
lower inoculating dose (105 cfu) also triggered an increased
expression of the two chemokines at Day 7 postinfection,
and this was particularly striking in the case of RANTES.
Interestingly, we did not observe any upregulation of either
MIP-1α and RANTES within limb muscles under the same
conditions (data not shown), and the levels of chemokine
upregulation in the diaphragm at both time points after
Pseudomonas infection were greater (relative to control)
than following acute LPS administration.
3.3. Cellular Mechanisms of Chemokine Gene Upregulation
in the Septic Diaphragm. Having shown that both RANTES
and MIP-1α are upregulated in the diaphragm by two
diﬀerent sepsis models in vivo, we next wished to establish
whether stimulation by LPS has direct eﬀects on the
expression of these chemokines by diaphragm muscle cells
in vitro. Ribonuclease protection assays were performed to
quantify RANTES and MIP-1α expression levels in primary
diaphragm muscle cell cultures (diﬀerentiated myotubes)
at 4 hours poststimulation with LPS. In the absence of
LPS stimulation, RANTES expression by diaphragmatic4 Mediators of Inﬂammation
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Figure 1: CC-class chemokine receptor gene expression in the diaphragm and limb muscle at baseline and during endotoxemia in vivo. (a)
Representative autoradiograph of ribonuclease protection assay data, showing CCR1 gene expression in the mouse diaphragm and tibialis
anterior (TA) muscles at 24 hours following injection of either LPS or saline. (b) Quantiﬁcation of CCR1 and CCR5 mRNA levels at 6 and
24 hours after LPS administration. Note that the samples for each time point were loaded onto separate gels, such that the absolute arbitrary
units depicted are valid for quantitative comparisons within but not between time points. All data are group means ± SE, n = 6m i c ep e r
group. Data are normalized to the L32 housekeeping gene. ∗P<. 05 for comparisons between diaphragm and TA within the same condition
(LPS or sham control); †P<. 05 for comparisons between LPS- and sham-control- (saline-) treated mice within the same type of muscle
(diaphragm or TA).
myotubes was observed, but only at a very low level, whereas
MIP-1α was not detectable. However, exposure of the cul-
tured diaphragmatic myotubes to LPS markedly upregulated
RANTES (see Figure 4(a))b u th a dn om e a s u r a b l ee ﬀect on
MIP-1α expression.
To further explore the mechanism of RANTES upregu-
lation by muscle cells after LPS stimulation, we transfected
C2C12 cells (skeletal muscle cell line) with a plasmid
containing the RANTES promoter linked to a luciferase
reporter gene, and the transfected cells were then once again
stimulated with LPS at the myotube stage. As shown in
Figure 4(b), there was a signiﬁcant increase in luciferase
expression in the LPS-stimulated group in comparison to
nonstimulated control cultures transfected with the same
plasmid (transfection eﬃciency of approximately 50% in
both groups). These data suggest that LPS-induced upreg-
ulation of RANTES expression in muscle cells involves
an increased level of transcription from the RANTES
promoter.
Because the RANTES promoter is a target for the
transcription factor NF-κB, we also examined the eﬀects of
an NF-κB inhibitor (PDTC) on RANTES gene expression
in primary cultured diaphragmatic myotubes stimulated
with LPS. Figure 5(a) demonstrates that PDTC dramaticallyMediators of Inﬂammation 5
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Figure 2: Eﬀects of endotoxemia on RANTES and MIP-1α gene expression in the diaphragm and limb muscle. (a) Ribonuclease protection
assay demonstrating RANTES and MIP-1α gene expression in the diaphragm and TA at 24 hours following LPS or saline administration.
(b) Quantiﬁcation of RANTES and MIP-1α mRNA levels at diﬀerent time points after LPS delivery. All data are group means ± SE, n = 6
mice per group. Data are normalized to the L32 housekeeping gene. ∗P<. 05 for comparisons between diaphragm and TA within the same
condition (LPS or sham control); †P<. 05 for comparisons between LPS- and sham control (saline)-treated mice within the same type of
muscle (diaphragm or TA).
downregulated the expression level of RANTES. These
ﬁndings suggest that NF-κB plays an important role in LPS-
induced RANTES expression by diaphragmatic myotubes.
On the other hand, NAC and catalase, two potent antiox-
idant compounds, had no measurable eﬀects on RANTES
expression (Figure 5(b)), suggesting that the free radical
generation which is known to occur in septic diaphragm
muscle [3, 9] is not a major factor in LPS-induced RANTES
upregulation.
Finally, the role of NF-κB in the LPS-induced RANTES
gene upregulation within diﬀerentiated myotubes was fur-
therstudiedusingastrategyofdominantnegativeinhibition.
Two diﬀerent dominant negative constructs were transfected
into C2C12 cells in order to inhibit IKKα and IKKβ,
which are involved in the alternate and classical NF-κB
pathways, respectively [32]. Figure 6 illustrates and conﬁrms
the role of the classical NF-κB pathway in LPS-induced
RANTES upregulation by muscle cells. Hence when C2C12
muscle cells were transfected with the dominant negative
IKKβ construct prior to LPS stimulation at the myotube
stage, there was a signiﬁcant inhibition of subsequent LPS-
induced RANTES expression, whereas IKKα inhibition had
no signiﬁcant eﬀect.
4. Discussion
Chemokines are responsible for modulating multiple aspects
of the host inﬂammatory response against infection, such as6 Mediators of Inﬂammation
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Figure 3: Bacterial dose- and time-dependence of chemokine gene expression in the diaphragm during Pseudomonas lung infection. (a)
RepresentativeribonucleaseprotectionassaydataindicatingRANTESandMIP-1αmRNAlevelsinthediaphragmattwoseparatetimepoints
(Day 2 and Day 7) following intratracheal instillation of Pseudomonas aeruginosa bacteria into the lungs at diﬀerent doses (5 × 105 or
1 × 106cfu). (b) Quantiﬁcation of RANTES and MIP-1α gene expression under the above conditions. Note that only the higher inoculating
dose of bacteria led to measurable chemokine upregulation at Day 2, while the lower dose was also able to induce a signiﬁcant increase in
RANTES gene expression by Day 7 postinfection. All data are group means ± SE, n = 6 mice per group. Data are normalized to the L32
housekeeping gene. ∗P<. 05 for comparisons to the sham control (CTL) condition. ND = signal not detectable.
leukocyte adhesion and migration, inﬂammatory cell activa-
tion, and the balance between type I and type II cytokine
production[21,33].SerumlevelsofbothRANTESandMIP-
1α are elevated in septic patients [34], and modulating the
biological activity of these chemokines has been shown to
alter the clinical course of sepsis in animal models [22, 35].
Two major receptors targeted by RANTES and MIP-1α in
vivo are CCR1 and CCR5, which are both expressed by a
broad spectrum of leukocytes. The authors [36] and Sell
et al. [37] have recently demonstrated both expression and
function of these receptors in isolated skeletal muscle cells.
To our knowledge, this is the ﬁrst study to demonstrate
an upregulation of CC class chemokine receptors and their
ligands within septic skeletal muscles. The major ﬁndings of
our study can be summarized as follows: (1) diaphragmatic
CCR1 gene expression is upregulated in response to acute
endotoxemia; (2) both acute endotoxemia and Pseudomonas
lung infection lead to increased expression of the CCR1
ligands, RANTES and MIP-1α, and this occurs to a signif-
icantly greater extent within the diaphragm as compared
to limb muscle; (3) LPS-induced upregulation of RANTES
expression by diaphragmatic muscle cells is transcriptionally
regulated and dependent upon the NF-κB transcription
factor pathway, whereas oxygen free radicals do not appear
to be involved in this process.
In the present investigation, two diﬀerent experimental
models of sepsis were employed. Both of these models
have previously been shown to be associated with sepsis-
induced upregulation of a number of proinﬂammatory
cytokines (see Table 1), along with diaphragmatic dysfunc-
tion. The acute administration of LPS has the advantage
of being a well-established and easily quantiﬁable septic
stimulus, whereas the Pseudomonas lung infection model
may be considered closer to most clinical situations, since itMediators of Inﬂammation 7
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Figure 4: LPS is able to activate upregulation of the RANTES gene in cultured muscle cells. (a) RANTES mRNA levels in primary
diaphragmatic myotubes under basal conditions (CTL) and in response to a 4-hour period of exposure to LPS (1μg/mL). All data are
normalized to the L32 housekeeping gene. ∗P<. 05 for comparisons to the control (CTL) condition. (b) RANTES promoter activation
as reﬂected by luciferase activity in C2C12 muscle cells previously transfected with a RANTES promoter-luciferase reporter gene plasmid.
Myotubes were again analyzed under basal conditions (CTL) and following a 4-hour period of stimulation with LPS (1μg/mL). ∗P<. 05
for comparisons to the control (CTL) condition.
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Figure 5: LPS-induced activation of RANTES is abrogated by pharmacological inhibition of NF-κB but not reactive oxygen species. (a)
The NF-κB inhibitor, PDTC, dramatically suppressed RANTES gene expression in primary diaphragmatic myotubes exposed to LPS. (b) In
contrast, two classical antioxidant compounds, N-acetylcysteine (NAC) and catalase, had no measurable eﬀect on RANTES gene expression
by diaphragmatic myotubes exposed to LPS under the same conditions. The primary myotube cultures were pretreated with PDTC or the
antioxidant compounds for one hour prior to initiating LPS stimulation for 4 hours (1μg/mL).
Control-GFP
RANTES
IKK-α IKK-β
(a)
0
1
2
3
R
A
N
T
E
S
m
R
N
A
e
x
p
r
e
s
s
i
o
n
CTL IKK-α IKK-β
∗
(b)
Figure 6: Eﬀects of dominant negative inhibition of the NF-κB pathway on LPS-induced RANTES gene expression. (a) Ribonuclease
protection assay showing the eﬀects of transfecting expression plasmids encoding dominant negative constructs for IKKα and IKKβ,o n
RANTES expression by C2C12 myotubes exposed to LPS. Control cells were transfected in an identical fashion with a control plasmid (CTL-
GFP) to determine transfection eﬃciency. (b) Quantiﬁcation of RANTES mRNA levels in LPS-stimulated myotubes previously transfected
with IKKα or IKKβ dominant negative mutant constructs. All data are normalized to the L32 housekeeping gene. ∗P<. 05 for comparisons
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Table 1: Sepsis-induced increases (fold changes) in prototypical
proinﬂammatory cytokines within the diaphragm.
LPS administration∗ Pseudomonas lung infection†
6 hours 24 hours 48 hours
TNF-α 2.3× 1.2× 18×
IL-6 5.8× 1.3× 73×
IL-1β 1.6× 1.1× 14.4×
∗ From [38]. †From [7].
encompasses additional virulence factors within the bacteria
besides endotoxin. Interestingly, in both models, the sepsis-
induced chemokine upregulation was more marked in the
diaphragm than in limb muscles. This pattern of preferential
diaphragmatic involvement mirrors the muscle functional
impairment and injury observed in several previous studies
[4, 5, 7]. Moreover, the fact that the diaphragm showed
greater constitutive as well as induced levels of chemokine
receptor/ligand upregulation is consistent with an emerging
concept that the diaphragm may be in certain respects
immunologically “primed” to respond in a more vigorous
fashion to inﬂammatory stimuli, perhaps to aid in its role as
a physical barrier to the passage of infectious agents between
the peritoneal and pleural cavities [38]. We have recently
reported that RANTES and MIP-1α are also upregulated
to a greater extent in the inﬂammatory milieu of the
muscular dystrophic diaphragm than in limb muscles from
the same animals [16]. In the present study, RANTES
also demonstrated more sustained upregulation than MIP-
1α in the chronic inﬂammatory situation associated with
Pseudomonaslunginfection.Thisisconsistentwithprevious
data showing an important role for RANTES in sustaining
chronic inﬂammation [39, 40].
Stimulation of cultured primary diaphragmatic (as well
as C2C12) muscle cells with LPS triggered an upregulation
of RANTES expression. Interestingly, we did not detect
an upregulation of MIP-1α within muscle cells following
exposuretoLPSinvitro,suggestingthatsepsis-inducedMIP-
1α expression by the diaphragm in vivo may originate from
nonmuscle cell types within the whole muscle. We have
previously reported that primary diaphragmatic myotubes
also demonstrate signiﬁcant upregulation of CCR1 but not
CCR5 during proinﬂammatory cytokine stimulation in vitro
[16], which is in keeping with the greater upregulation
of CCR1 during endotoxemia shown in the present study.
These observations reinforce the idea that skeletal muscle
ﬁbers have the ability to behave as “immune cells” and thus
actively participate in the response to various inﬂammatory
stimuli. For example, in cultured human muscle cells,
proinﬂammatory cytokines induce the expression of class I
and class II major histocompatibility molecules [41]. Indeed,
skeletal muscle cells have the ability to express a large
repertoire of immunologically relevant molecules [38, 41–
43].
To begin to dissect the molecular events underlying
RANTES upregulation within septic diaphragmatic muscle
cells, we ﬁrst determined that the RANTES promoter is
responsive to LPS in skeletal muscle cells, thus pointing to a
transcriptional mechanism. We then focused on examining
the role of NF-κB, a transcription factor that has been
shown to activate a large number of proinﬂammatory genes
in various cell types, including RANTES [30]. In addition,
inhibition of the IKKβ-dependent NF-κBh a sr e c e n t l yb e e n
shown to ameliorate muscle pathology in the setting of
muscular dystrophy [44] and after experimentally induced
muscle injury [45]. In our study, two distinct methods
were used to evaluate the involvement of NF-κB: pharma-
cological inhibition with PDTC and a dominant negative
transfection approach. This combination of complementary
methods allowed us to inhibit two critical protein complexes
which are required for the phosphorylation and degrada-
tion of IκB: the IKK and E3 ubiquitin ligase complexes,
respectively. The sequential actions of these two complexes
permit the liberation and subsequent translocation of NF-
κB into the nucleus in order to activate proinﬂammatory
gene transcription [32]. In keeping with our hypothesis,
both pharmacological and dominant negative molecular
inhibitions of the IKKβ-dependent classical NF-κBp a t h w a y
were eﬀective in suppressing LPS-induced upregulation of
RANTES. On the other hand, inhibition of the IKKα-
dependent alternative NF-κB pathway, and blockade of free
radicals with the antioxidants NAC or catalase, did not have
any eﬀect on LPS-induced RANTES gene expression under
the same experimental conditions, strongly suggesting that
these pathways were not involved.
What are the precise functional roles played by CC-
class chemokine upregulation within the septic diaphragm
muscle? The results of our study do not allow this question
to be deﬁnitively addressed, since this would require a model
in which muscle tissue-speciﬁc knockout of the receptor-
ligand interaction could be achieved in vivo. However, there
are a number of plausible scenarios. The most intuitively
obvious role for CC chemokines in this setting would be to
stimulate the recruitment of inﬂammatory cells, as has been
proposed in several other diseases involving skeletal muscle
[14–16]. For example, in the mdx mouse, a murine model
of Duchenne muscular dystrophy, the diaphragm exhibits a
pronounced inﬁltration by macrophages and lymphocyctes,
which parallels a marked overexpression of RANTES and
MIP-1α [16]. This is consistent with the inﬂammatory
cell types known to be attracted by these chemokines
[33].
In animal models of sepsis, inﬁltration of the diaphragm
by inﬂammatory cells has been observed in some but
not all studies. Hence in models of acute endotoxemia
and bacterial peritonitis induced by cecal ligation and
perforation,macrophageinﬁltrationhasbeenreportedinthe
diaphragm [4, 5]. The presence of inﬂammatory cells in the
diaphragm was associated with contractile impairment and
muscle ﬁber injury, both of which were partially prevented
byinhibitionofnitricoxidesynthase[4,5].Alongthesesame
lines, Supinski et al. [10] reported neutrophilic inﬁltration
of the diaphragm after systemic delivery of LPS, along
with an improvement in diaphragmatic contractility when
the superoxide-generating NADPH complex was inhibited.
However, while we demonstrate in this study that CC
chemokine upregulation occurs in the diaphragm duringMediators of Inﬂammation 9
Pseudomonas lung infection, we have previously reported
that inﬂammatory cells are not recruited to the diaphragm
in this model [7], suggesting the existence of alternative
functions for chemokines in septic skeletal muscle.
In this regard, another recently recognized function of
CC chemokines is in the regulation of cytokine production.
It has been found that both NK cells and CD8+ T cells
use RANTES and MIP-1α to help drive the Th1 cytokine
response [21] .I nh u m a nm o n o c y t e s ,R A N T E Si sa b l et o
directly induce the expression of several proinﬂammatory
cytokines/chemokines (e.g., IL-1β, MCP-1) and molecules
involved in extracellular matrix digestion (e.g., MMP-9) as
well as its own receptor, CCR1 [46]. In the cecal ligation
and perforation model of sepsis, it was recently shown
that administration of RANTES signiﬁcantly increases
lethality, and this is associated with an increased production
of multiple proinﬂammatory cytokines, which probably
underlies the reduction in survival [22]. Taken together,
these ﬁndings suggest that CC chemokines could act in an
autocrine or paracrine fashion to upregulate the expression
of other proinﬂammatory mediators within the diaphragm
during sepsis, and thereby contribute to contractile
dysfunction.
There is also evidence for an important contribution
of CC chemokines to muscle regeneration and recovery.
RANTES is reported to act as a chemotactic factor for
myoblasts [47], and gene expression proﬁling studies have
shown an enhanced expression of CC-class chemokines as
well as their receptors in injured muscles [48, 49]. Other
studies have shown that functional recovery from muscle
injury is impaired in mice rendered deﬁcient in MCP-1 or
its receptor, CCR2 [17, 18]. Our group has recently shown
that several CC chemokines, including MIP-1α,a r ea b l et o
stimulate myoblast proliferation [36]. Collectively, these data
suggest that at least under certain conditions, chemokines
may also play a beneﬁcial role in the repair of diaphragmatic
muscleﬁberinjurytriggeredbysepsis[5,6,24].Theultimate
impact of these CC chemokines upon septic diaphragm
function is likely dependent upon achieving the appropriate
magnitude as well as spatial and temporal equilibrium of
chemokine expression.
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